While our results support the utility of transcriptomic markers, other studies, particularly in lung cancer, have highlighted the importance of high clonal frequency in addition to CD39 protein and CXCL13 mRNA expressions in tumor-reactive T cells [32]. This evidence concerns the gene CXCL13 and neoplasm.